AlipourFG, AshooriMR, Pilehvar-SoltanahmadiY, ZarghamiN. An overview on biological functions and emerging therapeutic roles of apelin in diabetes mellitus. Diabetes Metab Syndr., 2017.
2.
ChenT, WuB, LinR. Association of apelin and apelin receptor with the risk of coronary artery disease: a meta-analysis of observational studies. Oncotarget., 2017.
3.
ChenZ, WuD, LiL, ChenL. Apelin/APJ System: A Novel Therapeutic Target for Myocardial Ischemia/Reperfusion Injury. DNA Cell Biol. 2016; 35(12):766–75.
4.
FolinoA, AccomassoL, GiachinoC, MontaroloPG, LosanoG, PagliaroP, et al.Apelin-induced Cardioprotection Against Ischemia/Reperfusion Injury: Roles of Epidermal Growth Factor and Src. Acta Physiol (Oxf). 2017.
5.
GourdyP, CazalsL, ThalamasC, SommetA, CalvasF, GalitzkyM, et al.Apelin administration improves insulin sensitivity in overweight men during hyperinsulinaemic-euglycaemic clamp. Diabetes Obes Metab., 2017.
6.
HuangZ, WuL, ChenL. Apelin/APJ system: a novel potential therapy target for kidney disease. J Cell Physiol., 2017.
7.
BertaJ, HodaMA, LaszloV, RozsasA, GarayT, TorokS, et al.Apelin promotes lymphangiogenesis and lymph node metastasis. Oncotarget. 2014; 5(12):4426–37.
8.
KimJD, KangY, KimJ, PapangeliI, KangH, WuJ, et al.Essential role of Apelin signaling during lymphatic development in zebrafish. Arterioscler Thromb Vasc Biol. 2014; 34(2):338–45.
9.
KarpinichNO, CaronKM. Apelin signaling: new G protein-coupled receptor pathway in lymphatic vascular development. Arterioscler Thromb Vasc Biol. 2014; 34(2):239–41.
